1、 张稷,陈静瑜,徐凯峰.肺淋巴管平滑肌瘤病肺移植治疗研究进展[J]. 中华结核和呼吸杂志,2011, 34(10):771-773. 张稷,陈静瑜,徐凯峰.肺淋巴管平滑肌瘤病肺移植治疗研究进展[J]. 中华结核和呼吸杂志,2011, 34(10):771-773.
2、 GOLDBERG H J,HARARI S,MCCORMACK F X,et al.Efficacy and safety of everolimus for the treatment of lymphangioleiomyomatosis:a phase II study[C]//The LAM Foundation 17th Annual International Lymphangioleiomyomatosis Research Conference and Patient and Family Educational LAMposium.Chicago,2014:27-29. GOLDBERG H J,HARARI S,MCCORMACK F X,et al.Efficacy and safety of everolimus for the treatment of lymphangioleiomyomatosis:a phase II study[C]//The LAM Foundation 17th Annual International Lymphangioleiomyomatosis Research Conference and Patient and Family Educational LAMposium.Chicago,2014:27-29.
3、 BISSLER J J,KINGSWOOD J C,RADZIKOWSKA E,et al.Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis(EXIST-2):aulticentre,randomised,double-blind,placebo-controlled trial[J]. Lancet,2013,381(9869):817-824. BISSLER J J,KINGSWOOD J C,RADZIKOWSKA E,et al.Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis(EXIST-2):aulticentre,randomised,double-blind,placebo-controlled trial[J]. Lancet,2013,381(9869):817-824.
4、 MCCORMACK F X,INOUE Y,MOSS J,et al.Efficacy and safety of sirolimus in lymphangioleiomyomatosis[J]. N Engl J Med,2001,364(17):1595-1606. MCCORMACK F X,INOUE Y,MOSS J,et al.Efficacy and safety of sirolimus in lymphangioleiomyomatosis[J]. N Engl J Med,2001,364(17):1595-1606.
5、 BISSLER J J,MCCORMACK F X,YOUNG L R,et al.Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis[J]. N Engl J Med,2008,358(2):140-151. BISSLER J J,MCCORMACK F X,YOUNG L R,et al.Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis[J]. N Engl J Med,2008,358(2):140-151.
6、 HARARI S, CASSANDRO R, CHIODINI I, et al. Effect of a gonadotrophin-releasinghormone analogue on lung functionin lymphangioleiomyomatosis[J]. Chest,2008,133(2):448-454. HARARI S, CASSANDRO R, CHIODINI I, et al. Effect of a gonadotrophin-releasinghormone analogue on lung functionin lymphangioleiomyomatosis[J]. Chest,2008,133(2):448-454.
7、 TAVEIRA-DASILVA A M,STYLIANOU M P,HEDIN CJ,et al.Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone[J]. Chest,2004,126(6):1867-1874. TAVEIRA-DASILVA A M,STYLIANOU M P,HEDIN CJ,et al.Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone[J]. Chest,2004,126(6):1867-1874.
8、 JOHNSON S R,CORDIER J F,LAZOR R,et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis[J]. Eur Respir J,2010,35(1):14-26. JOHNSON S R,CORDIER J F,LAZOR R,et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis[J]. Eur Respir J,2010,35(1):14-26.
9、 YOUNG L R, LEE H S, INOUE Y, et al. Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response:a prospective analysis of the multicenter international lymphangioleiomyomatosis efficacy of sirolimus(MILES)trial[J]. Lancet Respir Med,2013,1(6):445-452. YOUNG L R, LEE H S, INOUE Y, et al. Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response:a prospective analysis of the multicenter international lymphangioleiomyomatosis efficacy of sirolimus(MILES)trial[J]. Lancet Respir Med,2013,1(6):445-452.
10、 XU K F,ZHANG P,TIAN X,et al.The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis(LAM)[J]. Respir Med,2013,107(2):263-268. XU K F,ZHANG P,TIAN X,et al.The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis(LAM)[J]. Respir Med,2013,107(2):263-268.
11、 ISSAKA R B, OOMMEN S, GUPTA S K, et al. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cell through autocrine crosstalk with endothelium[J]. Am J Pathol,2009,175(4):1410-1420. ISSAKA R B, OOMMEN S, GUPTA S K, et al. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cell through autocrine crosstalk with endothelium[J]. Am J Pathol,2009,175(4):1410-1420.
12、 CAI X,PACHECO-RODRIGUEZ G,FAN Q Y,et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis[J]. Am J Respir Crit Care Med,2010,182(11):1410-1418. CAI X,PACHECO-RODRIGUEZ G,FAN Q Y,et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis[J]. Am J Respir Crit Care Med,2010,182(11):1410-1418.
13、 TRAVIS W D,BRAMBILLA E,MULLER-HERMLINK H K,et al. Pathology and genetics:tumours of lung,pleura,thymus and heart[M]. Lyon:IARC,2004. TRAVIS W D,BRAMBILLA E,MULLER-HERMLINK H K,et al. Pathology and genetics:tumours of lung,pleura,thymus and heart[M]. Lyon:IARC,2004.
14、 CORNOG J L Jr, ENTERLINE H T. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma [J]. Cancer,1966,19(12):1909-1930. CORNOG J L Jr, ENTERLINE H T. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma [J]. Cancer,1966,19(12):1909-1930.
15、 IRULOH C,KERIAKOS R,SMITH D J,et al. Renal angiomyolipoma and lymphangioleio-myomatosis in pregnancy[J]. J Obstet Gynaecol,2013,33(6):542-546. IRULOH C,KERIAKOS R,SMITH D J,et al. Renal angiomyolipoma and lymphangioleio-myomatosis in pregnancy[J]. J Obstet Gynaecol,2013,33(6):542-546.
16、 MCCORMACK F K. Lymphangioleiomyomatosis: a clinical update [J]. Chest,2008,133(2):507-516. MCCORMACK F K. Lymphangioleiomyomatosis: a clinical update [J]. Chest,2008,133(2):507-516.
17、 陈勃江,李为民.淋巴管平滑肌瘤病诊疗现状[J]. 中国综合临床,2010,26(10):1113-1114. 陈勃江,李为民.淋巴管平滑肌瘤病诊疗现状[J]. 中国综合临床,2010,26(10):1113-1114.
18、 JOHOSON S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms[J]. Thorax,1999( 54):254. JOHOSON S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms[J]. Thorax,1999( 54):254.
19、 郎建敏,石彦明.肺淋巴管平滑肌瘤病[J]. 国际呼吸杂志,2007,27(10):740-742. 郎建敏,石彦明.肺淋巴管平滑肌瘤病[J]. 国际呼吸杂志,2007,27(10):740-742.
20、 YU J J,ROBB V A,MORRISON T A.et al.Estrogen promotes the survival and pulmonaru metastasis of tuverin-null cells[J]. Proc Natl Acad Sci USA,2009,106(8):2635-2640. YU J J,ROBB V A,MORRISON T A.et al.Estrogen promotes the survival and pulmonaru metastasis of tuverin-null cells[J]. Proc Natl Acad Sci USA,2009,106(8):2635-2640.
21、 STRIZHEVA G D,CARSILLO T,KRUGER W D,et al.The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis[J]. Am J Respir Crit Care Med,2001,163(1):253-258. STRIZHEVA G D,CARSILLO T,KRUGER W D,et al.The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis[J]. Am J Respir Crit Care Med,2001,163(1):253-258.
22、 RYU J H,MOSS J,BECK G J.The NHLBI lympangioleiomyomatosis registry:characteristics of 230 patients at enrollment[J]. Am J Respir Crit Care Med,2006,173(1):105-111. RYU J H,MOSS J,BECK G J.The NHLBI lympangioleiomyomatosis registry:characteristics of 230 patients at enrollment[J]. Am J Respir Crit Care Med,2006,173(1):105-111.
23、 侯杰. 淋巴管平滑肌瘤[J]. 中华结核和呼吸杂志,2002,25(9):566-567. 侯杰. 淋巴管平滑肌瘤[J]. 中华结核和呼吸杂志,2002,25(9):566-567.
